NCT07477457: A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
- State
- Under way
- Phase
- Phase 2
- People
- 45 planned
- Started
- 11 Mar 2026
- Primary completion
- Mar 2028
- Arms
- Relapsed, Metastatic Osteosarcoma
- Results
- None posted
- 11 Mar 2026: Trial started
- 17 Mar 2026: Trial registered